Skip to content

JBIO - Jade Biosciences, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchJ

Jade Biosciences, Inc.

JBIO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

J

JBIOJade Biosciences, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $28.00
52-wk low: $6.91
Prev close: $17.96
Mkt cap: $1.43B
P/B: 3.4x
Profit margin: +0.0%

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$413.6M

CI
Citadel
Ken Griffin · Q2 2026 13F
$20.7M
position
BA
Balyasny
Dmitry Balyasny · Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 15.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.4B

Valuation

P/B3.40

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: JBIO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.43B

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Op margin

+0.0%

ROE

-89.2%

$19.5M

position

MW

Marshall Wace

Q2 2026 13F

$13.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for JBIO

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.76-15.2%

-$0.66 expected

Next report

What the street expects next

EPS expected

-$0.54

-$0.54 to -$0.54

Revenue expected

$0.00

8 analysts

Estimate drift

0.54

Change in 30 days

-89.2%

ROA-33.6%

Growth